Background The TB043 study is a human challenge study to evaluate innate and adaptive immune responses to a controlled human infection with BCG, administered by the aerosol inhaled route in healthy, BCG-naïve, UK adult volunteers. BCG stands for Bacillus Calmette-Guérin vaccine, designed to ... READ MORE

Background The FLU008 study was a phase I, open label study to determine the safety and immunogenicity of candidate influenza vaccine MVA-NP+M1, manufactured on the AGE1.CR.pIX novel avian cell line. Earlier trials had already shown this vaccine to be safe and effective in producing an immune ... READ MORE